伟思医疗：2024年净利润1.02亿元，同比下降25.16%

Group 1 - The core viewpoint of the announcement indicates that the company experienced a decline in both revenue and net profit for the year 2024, with revenue at 400 million yuan, a year-on-year decrease of 13.45% [1] - The net profit attributable to shareholders of the listed company was 102 million yuan, reflecting a year-on-year decline of 25.16% [1] - The company plans to distribute a cash dividend of 8 yuan (including tax) for every 10 shares to all shareholders [1]